Invasive fungal infections constitute a substantial global health burden, with invasive candidiasis representing approximately 70% of reported cases worldwide. The emergence of antifungal resistance among species has further exacerbated this challenge to healthcare systems. Recent epidemiological studies have documented a concerning shift towards non-albicans species, exhibiting reduced antifungal susceptibility, in invasive candidiasis cases.
View Article and Find Full Text PDF